KD025-208: A Phase 2a Study of KD025 for Patients With Chronic Graft Versus Host Disease (cGVHD)-Pharmacodynamics and Updated Results

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2019年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [1] KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics (PD) and Updated Results
    Jagasia, Madan
    Salhotra, Amandeep
    Bachier, Carlos R.
    Essell, James H.
    Weisdorf, Daniel J.
    Lazaryan, Aleksandr
    Zoghi, Behyar
    Green, Laurie S.
    Schueller, Olivier
    Zanin-Zhorov, Alexandra
    Weiss, Jonathan M.
    Eiznhamer, David A.
    Aggarwal, Sanjay K.
    Blazar, Bruce R.
    Lee, Stephanie J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [2] KD025-208: A Phase 2a Study of 025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics and Updated Results
    Jagasia, Madan
    Salhotra, Amandeep
    Bachier, Carlos R.
    Essell, James
    Weisdorf, Daniel J.
    Zoghi, Behyar
    Green, Laurie S.
    Schueller, Olivier
    Zanin-Zhorov, Alexandra
    Weiss, Jonathan M.
    Eiznhamer, David
    Aggarwal, Sanjay K.
    Blazar, Bruce R.
    Lee, Stephanie J.
    BLOOD, 2018, 132
  • [3] KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) - Long-Term Follow-up of a Phase 2a Study (KD025-208)
    Jagasia, Madan
    Salhotra, Amandeep
    Bachier, Carlos R.
    Zoghi, Behyar
    Lazaryan, Aleksandr
    Weisdorf, Daniel J.
    Essell, James
    Green, Laurie S.
    Schueller, Olivier
    Huang, Lindy
    Yang, Zhongming
    Eiznhamer, David
    Aggarwal, Sanjay K.
    Blazar, Bruce R.
    Lee, Stephanie J.
    BLOOD, 2019, 134
  • [4] KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) - Long-Term Follow-up of a Phase 2a Study (KD025-208)
    Weisdorf, Daniel J.
    Jagasia, Madan
    Salhotra, Amandeep
    Bachier, Carlos R.
    Zoghi, Behyar
    Lazaryan, Aleksandr
    Essell, James H.
    Green, Laurie S.
    Schueller, Olivier
    Yang, Zhongming
    Eiznhamer, David A.
    Aggarwal, Sanjay K.
    Blazar, Bruce R.
    Lee, Stephanie
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S187 - S188
  • [5] KD025 for Patients with Chronic Graft-Versus-Host Disease (CGVHD) - Long-Term Follow-up of a Phase 2A Study (KD025-208)
    Lazaryan, Aleksandr
    Salhotra, Amandeep
    Bachier, Carlos
    Zoghi, Behyar
    Weisdorf, Daniel
    Essell, James
    Green, Laurie
    Schueller, Olivier
    Yang, Zhongming
    Eiznhamer, David
    Aggarwal, Sanjay K.
    Blazar, Bruce R.
    Lee, Stephanie J.
    Jagasia, Madan
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 79 - 80
  • [6] Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)
    Lazaryan, Alelcsandr
    Lee, Stephanie J.
    Salhotra, Amandeep
    Jagasia, Madan
    Essell, James H.
    Zanin-Zhorov, Alexandra
    Mac Gillivray, Beth
    Schueller, Olivier
    Eiznhamer, David A.
    Blazar, Bruce R.
    Ryan, John L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S48 - S48
  • [7] Initial Results of KD025-208: A Phase 2a Open Label Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease
    Lazaryan, Aleksandr
    Lee, Stephanie J.
    Salhotra, Amandeep
    Jagasia, Madan
    Essell, James
    Zanin-Zhorov, Alexandra
    Mac Gillivray, Beth
    Schueller, Olivier
    Eiznhamer, David
    Blazar, Bruce
    Ryan, John L.
    BLOOD, 2017, 130
  • [8] KD025-208: A phase 2A open-label trial of KD025-208 for steroid-dependent chronic graft-versus-host disease (CGVHD): Updated safety, efficacy, and pharmacodynamic results
    Bachier, Carlos R.
    Zoghi, Behyar
    Salhotra, Amandeep
    Weisdorf, Daniel J.
    Lazaryan, Aleksandr
    Essell, James
    Zanin-Zhorov, Alexandra
    Weiss, Jonathan M.
    Green, Laurie S.
    Schueller, Olivier
    Eiznhamer, David
    Yang, Zhongming
    Aggarwal, Sanjay K.
    Lee, Stephanie J.
    Blazar, Bruce R.
    Jagasia, Madan
    BONE MARROW TRANSPLANTATION, 2019, 54 : 83 - 84
  • [9] KD025-208: A Phase 2 Open-Label Trial of KD025-208 for Steroid-Dependent Chronic Graft-Versus-Host Disease (cGVHD)
    Jagasia, Madan
    Lazaryan, Aleksandr
    Salhotra, Amandeep
    Zoghi, Beyhar
    Essell, James
    Bachier, Carlos
    Skelton, Emily
    Schueller, Olivier
    Eiznhamer, David
    Ryan, John
    Lee, Stephanie J.
    BONE MARROW TRANSPLANTATION, 2018, 53 : 67 - 68
  • [10] ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
    Jagasia, Madan
    Lazaryan, Aleksandr
    Bachier, Carlos R.
    Salhotra, Amandeep
    Weisdorf, Daniel J.
    Zoghi, Behyar
    Essell, James
    Green, Laurie
    Schueller, Olivier
    Patel, Jeegar
    Zanin-Zhorov, Alexandra
    Weiss, Jonathan M.
    Yang, Zhongming
    Eiznhamer, David
    Aggarwal, Sanjay K.
    Blazar, Bruce R.
    Lee, Stephanie J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (17) : 1888 - +
12345